Micro analyzer base +4

Active Awarded Last action

Contract number
36C24522F0220
Awardee
Awarding agency
Obligated
$125,313

Award facts

Contract value 63% obligated
  • $125,312.57 Current, with exercised options
  • $197,581.76 Potential, with all options
Completion date 93% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Sparks Glencoe, MD 21152, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00008 · Option year 4 micro analyzer base +4 $29,493
Supplemental Agreement for work within scope P00007 $11,045
Exercise an Option P00006 · Option year 3 micro analyzer base +4 $24,090
Funding Only Action P00005 $5,437
Supplemental Agreement for work within scope P00004 -$5,909
Supplemental Agreement for work within scope P00003 -$11,112
Exercise an Option P00002 $24,090
Exercise an Option P00001 · Option year 1 micro analyzer base +4 $24,090
Original award $24,090

About this award

This delivery order, awarded March 7, 2022, to Becton, Dickinson and Company's Infectious Disease Systems division, provides a Micro Analyzer Base +4 system and option year 4 services valued at $197,581.76 on a firm fixed-price basis. The order is issued under the GSA Schedule for Critical Analyzers, Laboratory (FSS-66-III), a General Services Administration vehicle enabling federal agencies to procure specialized diagnostic laboratory equipment and related services. The work will be performed in Sparks Glencoe, Maryland, with an ultimate completion date of March 6, 2027. The Veterans Integrated Service Network 5, a component of the Department of Veterans Affairs, is the funding agency. No small business set-aside was applied to this competitive award.

Becton, Dickinson and Company, a global medical technology manufacturer headquartered in Franklin Lakes, New Jersey, has established itself as a strategic supplier to federal healthcare agencies through its extensive portfolio of diagnostic products and services. The company's Infectious Disease Systems division specializes in blood culture analyzers, microbiology testing equipment, and molecular diagnostics—technologies fundamental to clinical laboratory operations at VA medical centers. BD's substantial federal contract experience, with prime contract awards exceeding $500 million, positions it as a primary vendor for advanced diagnostic instrumentation across multiple Veterans Integrated Service Networks and other federal healthcare entities.

Quick answers

Who was awarded contract 36C24522F0220?

36C24522F0220 was awarded to Becton, Dickinson And Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 7, 2022.

How much is contract 36C24522F0220 worth?

The government has obligated $125,313 on 36C24522F0220. Its potential value, with all options, is $197,582.

Is contract 36C24522F0220 an order under another contract?

Yes. 36C24522F0220 is a delivery order under V797D40095, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 36C24522F0220 competed?

The extent of competition for 36C24522F0220 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award